Accelerate Diagnostics, Inc. (NASDAQ: AXDX) is an in vitro diagnostics company dedicated to providing solutions to the global challenge of drug resistant organisms and hospital acquired infections. We are focused on developing and commercializing innovative instrumentation for the rapid identification and antimicrobial susceptibility testing of infectious pathogens. The Company’s revolutionary ID/AST system utilizes a proprietary culture-free process, with both genomic and phenotypic detection technologies, that significantly decreases time to result while achieving high sensitivity and specificity.
Location: United States, Arizona, Tucson
Employees: 201-500
Phone: 520.365.3100
Founded date: 1987
Investors 1
Date | Name | Website |
- | CARB-X | carb-x.org |
Mentions in press and media 8
Date | Title | Description | Source |
15.11.2023 | Cytovale Snags $84M To Commercialize Early Sepsis Detection ... | Sepsis kills more than 11 million people worldwide each year and contributes to 20% of all global de... | medcitynew... |
23.09.2021 | Accelerate Diagnostics : Announces Agreements to Exchange Ap... | Accelerate Diagnostics Announces Agreements to Exchange Approximately $51 Million in Principal Amoun... | marketscre... |
23.09.2021 | Accelerate Diagnostics : Announces Agreements to Exchange Ap... | TUCSON, Ariz., Sept. 23, 2021 /PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today anno... | marketscre... |
03.08.2021 | Accelerate Diagnostics Announces CE Mark and Availability in... | TUCSON, Ariz., Aug. 3, 2021 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ:AXDX) today annou... | prnewswire... |
07.07.2021 | Accelerate Diagnostics Launches a Fast Antimicrobial Suscept... | TUCSON, Ariz., July 7, 2021 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX) today anno... | prnewswire... |
09.06.2021 | ACCELERATE DIAGNOSTICS, INC. Accelerate Diagnostics : Recei... | Accelerate Diagnostics Receives CARB-X Award to Develop Rapid Optical Imaging Technology for Sepsis ... | marketscre... |
23.02.2021 | Accelerate Diagnostics Reports Fourth Quarter and Full-Year ... | TUCSON, Ariz., Feb. 23, 2021 /PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today ann... | prnewswire... |
24.10.2019 | New diagnostic tools are essential in the battle against ant... | A century ago, a severe bacterial infection was often a death sentence. With the advent of penicilli... | statnews.c... |